Rezolute, Inc. Common Stock (NV) RZLT
Key Stats
- Today's Range
- $4.86 – $5.17
- 50-Day Range
- $2.83 – $5.26
- 52-Week Range
- $1.07 – $11.46
- Volume
- 6.58 million shs
- Average Volume
- 2.14 million shs
- Market Cap
- $485.31 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.00%
- Days to Cover
- 1.00
About Rezolute, Inc. Common Stock (NV)
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.